Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.
H+: I might spend the whole day thinking about politics, economics — thinking about solutions to knotty human problems — and then I start thinking that a lot of this is hardwired. Maybe nothing really good is going to happen unless we change our wiring. Unless we actually technically evolve. Is that part of the intrigue with biotechnology?